ICU Medical Inc
NASDAQ:ICUI

Watchlist Manager
ICU Medical Inc Logo
ICU Medical Inc
NASDAQ:ICUI
Watchlist
Price: 168.46 USD -0.23% Market Closed
Market Cap: 4.1B USD
Have any thoughts about
ICU Medical Inc?
Write Note

ICU Medical Inc
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ICU Medical Inc
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
ICU Medical Inc
NASDAQ:ICUI
Current Portion of Long-Term Debt
$52m
CAGR 3-Years
343%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Haemonetics Corp
NYSE:HAE
Current Portion of Long-Term Debt
$5.4m
CAGR 3-Years
-60%
CAGR 5-Years
-37%
CAGR 10-Years
12%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Current Portion of Long-Term Debt
$422m
CAGR 3-Years
41%
CAGR 5-Years
104%
CAGR 10-Years
14%
Align Technology Inc
NASDAQ:ALGN
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Lantheus Holdings Inc
NASDAQ:LNTH
Current Portion of Long-Term Debt
$564.7m
CAGR 3-Years
279%
CAGR 5-Years
123%
CAGR 10-Years
N/A
Merit Medical Systems Inc
NASDAQ:MMSI
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

ICU Medical Inc
Glance View

Market Cap
4.1B USD
Industry
Health Care

ICU Medical, Inc. engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. The company is headquartered in San Clemente, California and currently employs 8,500 full-time employees. The firm provides infusion systems, infusion consumables and critical care products used in hospital, alternate site and home care settings. The firm's product portfolio includes IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle free connectors. Its oncology products include ChemoLock and ChemoClave. Its IV consumables include Clave IV Connector Technology, IV Sets, Peripheral IV Catheters and Disinfecting Caps. Its primary critical care products include Cogent, CardioFlo, TDQ and OptiQ, TriOx, Transpac and SafeSet. Its IV Solutions products include IV Therapy and Diluents, and Irrigation. Its Infusion System products include Infusion Pump Hardware, IV Mediation Safety Software and Professional Services. The company offers blood pressure monitoring system.

ICUI Intrinsic Value
190.76 USD
Undervaluation 12%
Intrinsic Value
Price

See Also

What is ICU Medical Inc's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
52m USD

Based on the financial report for Sep 30, 2024, ICU Medical Inc's Current Portion of Long-Term Debt amounts to 52m USD.

What is ICU Medical Inc's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 3Y
343%

Over the last year, the Current Portion of Long-Term Debt growth was 12%. The average annual Current Portion of Long-Term Debt growth rates for ICU Medical Inc have been 343% over the past three years .

Back to Top